Publications

Export 94 results:
Auteur Title Type [ Année(Asc)]
Filtres: Mot-clé is Aged  [Enlever les filtres]
2016
Burns RJ, Deschênes SS, Schmitz N.  2016.  Associations between coping strategies and mental health in individuals with type 2 diabetes: Prospective analyses.. Health Psychol. 35(1):78-86.
Richard-Devantoy S, Ding Y, Turecki G, Jollant F.  2016.  Attentional bias toward suicide-relevant information in suicide attempters: A cross-sectional study and a meta-analysis.. J Affect Disord. 196:101-8.
DuBois JM, Rousset OG, Rowley J, Porras-Betancourt M, Reader AJ, Labbe A, Massarweh G, Soucy J-P, Rosa-Neto P, Kobayashi E.  2016.  Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.. Eur J Nucl Med Mol Imaging. 43(1):152-62.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Takeuchi H, Gerretsen P, Iwata Y, Patel R, Mulsant BH et al..  2016.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
Gordon MForrest, Lenderking WR, Duhig A, Chandler J, J Lundy J, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S et al..  2016.  Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.. Alzheimers Dement. 12(1):75-84.
Leduc V, Théroux L, Dea D, Dufour R, Poirier J.  2016.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.. J Mol Neurosci. 58(1):109-19.
Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.  2016.  Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.. J Alzheimers Dis. 51(4):1237-47.
Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ et al..  2016.  Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.. Lancet. 388(10062):2873-2884.
Gauthier S, Rosa-Neto P, Kass JS.  2016.  Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients.. Continuum (Minneap Minn). 22(2 Dementia):615-8.
Freitas C, Deschênes S, Au B, Smith K, Schmitz N.  2016.  Evaluating lifestyle and health-related characteristics of older adults with co-occurring depressive symptoms and cardiometabolic abnormalities.. Int J Geriatr Psychiatry. 31(1):66-75.
Smith KJ, Pedneault M, Schmitz N.  2016.  Investigation of anxiety and depression symptom co-morbidity in a community sample with type 2 diabetes: Associations with indicators of self-care.. Can J Public Health. 106(8):e496-501.
Dickie DAlexander, Karama S, Ritchie SJ, Cox SR, Sakka E, Royle NA, Aribisala BS, Hernández MValdés, Maniega SMuñoz, Pattie A et al..  2016.  Progression of White Matter Disease and Cortical Thinning Are Not Related in Older Community-Dwelling Subjects.. Stroke. 47(2):410-6.
Lonergan M, Saumier D, Tremblay J, Kieffer BL, Brown TG, Brunet A.  2016.  Reactivating addiction-related memories under propranolol to reduce craving: A pilot randomized controlled trial.. J Behav Ther Exp Psychiatry. 50:245-9.

Pages


McGill Logo

CIUSSS ouest montreal logo

 



  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre